Li et al (36) observed that ketamine rapidly activated the mTOR pathway, leading to increased expression levels of synaptic signaling proteins and increased number and function of new spine synapses in the prefrontal cortex of rats, while inhibition of mTOR signaling completely blocked ketamine-mediated induction of synaptogenesis and behavioral responses in models of depression. The gene discussed is MTOR; the disease is major depressive disorder.